Corcept Therapeutics | CORT - 销售毛利



金融业
股票价格
USD
资产
USD 814.88M
现金及等价物
USD 108.74M
销售成本
USD 2.88M
流动资产
USD 426.03M
流动负债
USD 149.19M
债务
USD 6.11M
EBIT
USD -49.6M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD -0.3
股本和储备
USD 637.99M
销售毛利
USD 162.02M
债务利息支出
USD 814.88M
利息收入
USD 5.42M
市值
USD 9.33B
净收入
USD -31.76M
营业费用
USD 214.5M
营业利润
USD -49.6M
普通股股本
USD 107.33M
PE价格收益
113.58
税前利润
USD 9.91M
销售收入
USD 164.9M
销售和管理费用
USD 128.04M
股票
USD 12.89M
贸易债权人
USD 33.31M
应收帐款人
USD 39.07M


销售毛利 更改 日
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Ardelyx USD 89.66M 24.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Canopy Growth CAD 8.26M 13.2M 2026-03
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
J&J USD 17.24B 642M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Merck USD 10.85B 2.57B 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 10.07B 184M 2026-03
Novartis USD 10.07B 758M 2026-03
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 126.64M 15.61M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
TG Therapeutics USD 171.41M 16.98M 2026-03